Dartmouth TB Vaccine Moves One Step Closer to a Full Phase 3 Efficacy Trial – News Medical Life Sciences

Read article - Quotes Ford von Reyn, professor of medicine, in an article about the results of a phase 2 trial of the DAR-901 tuberculosis vaccine conducted by von Reyn and colleges at Dartmouth. The study showed that the vaccine was safe and induced immune responses against the disease.